Βιβλιογραφική Τεκμηρίωση:
Disease-modifying agents and experimental treatments of rheumatoid arthritis.Weinblatt ME, Maier AL.Clin Orthop Relat Res. 1991 Apr;(265):103-15.
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis. Stuart WH, Cohan S, Richert JR, Achiron A.Neurology. 2004 Dec 14;63(11 Suppl 5):S19-27.
Disease-modifying agents in multiple sclerosis. Coyle PK.Ann Indian Acad Neurol. 2009 Oct;12(4):273-82.